The expression of mouse CLEC-2 on leucocyte subsets varies according to their anatomical location and inflammatory state

European Journal of Immunology

Volumn 45, Issue 9, 2015, Pages 2484-2493

  Lowe, Kate L ^a   Navarro Núñez, Leyre ^a   Bénézech, Cécile ^a,d   Nayar, Saba ^a   Kingston, Bethany L ^a,b   Nieswandt, Bernhard ^c   Barone, Francesca ^a   Watson, Steve P ^a   Buckley, Christopher D ^a   Desanti, Guillaume E ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

CLEC 2; Inflammation; Leucocytes; Mouse; Tamoxifen

Indexed keywords

C TYPE LECTIN LIKE RECEPTOR 2; CD11B ANTIGEN; LECTIN RECEPTOR; UNCLASSIFIED DRUG; CHEMOKINE RECEPTOR; CLEC-2 PROTEIN, MOUSE; GR-1 PROTEIN, MOUSE; LECTIN; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BLOOD; BONE MARROW CELL; CONTROLLED STUDY; HEMATOPOIETIC CELL; HOMEOSTASIS; INFLAMMATION; LEUKOCYTE; LYMPHOCYTE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; ANIMAL; ANTAGONISTS AND INHIBITORS; ANTIBODY SPECIFICITY; CELL MOTION; CHEMICALLY INDUCED; DEFICIENCY; DENDRITIC CELL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LYMPH NODE; PATHOLOGY; SIGNAL TRANSDUCTION; SPLEEN; THROMBOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD11B; B-LYMPHOCYTES; BLOOD PLATELETS; CELL MOVEMENT; DENDRITIC CELLS; GENE EXPRESSION REGULATION; INFLAMMATION; LECTINS, C-TYPE; LIPOPOLYSACCHARIDES; LYMPH NODES; MICE; MICE, TRANSGENIC; MYELOID CELLS; ORGAN SPECIFICITY; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION; SPLEEN;

EID: 84940959573     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201445314     Document Type: Article

References (52)

1. Sigl, V. and Penninger, J. M., RANKL/RANK - from bone physiology to breast cancer. Cytokine Growth Factor Rev. 2014. 25: 205-214.
2. Navarro-Nunez, L., Langan, S. A., Nash, G. B. and Watson, S. P., The physiological and pathophysiological roles of platelet CLEC-2. Thromb. Haemost. 2013. 109: 991-998.
3. Williams, M. C., Cao, Y., Hinds, A., Rishi, A. K. and Wetterwald, A., T1 alpha protein is developmentally regulated and expressed by alveolar type I cells, choroid plexus, and ciliary epithelia of adult rats. Am. J. Respir. Cell Mol. Biol. 1996. 14: 577-585.
4. Breiteneder-Geleff, S., Matsui, K., Soleiman, A., Meraner, P., Poczewski, H., Kalt, R., Schaffner, G. et al., Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am. J. Pathol. 1997. 151: 1141-1152.
5. Farr, A., Nelson, A. and Hosier, S., Characterization of an antigenic determinant preferentially expressed by type I epithelial cells in the murine thymus. J. Histochem. Cytochem. 1992. 40: 651-664.
6. Hou, T. Z., Bystrom, J., Sherlock, J. P., Qureshi, O., Parnell, S. M., Anderson, G., Gilroy, D. W. et al., A distinct subset of podoplanin (gp38) expressing F4/80+ macrophages mediate phagocytosis and are induced following zymosan peritonitis. FEBS Lett. 2010. 584: 3955-3961.
7. Farr, A. G., Berry, M. L., Kim, A., Nelson, A. J., Welch, M. P. and Aruffo, A., Characterization and cloning of a novel glycoprotein expressed by stromal cells in T-dependent areas of peripheral lymphoid tissues. J. Exp. Med. 1992. 176: 1477-1482.
8. Wetterwald, A., Hoffstetter, W., Cecchini, M. G., Lanske, B., Wagner, C., Fleisch, H. and Atkinson, M., Characterization and cloning of the E11 antigen, a marker expressed by rat osteoblasts and osteocytes. Bone 1996. 18: 125-132.
9. Schacht, V., Ramirez, M. I., Hong, Y. K., Hirakawa, S., Feng, D., Harvey, N., Williams, M. et al., T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. Embo. J. 2003. 22: 3546-3556.
10. Bertozzi, C. C., Schmaier, A. A., Mericko, P., Hess, P. R., Zou, Z., Chen, M., Chen, C. Y. et al., Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood 2010. 116: 661-670.
11. Hess, P. R., Rawnsley, D. R., Jakus, Z., Yang, Y., Sweet, D. T., Fu, J., Herzog, B. et al., Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life. J. Clin. Invest. 2014. 124: 273-284.
12. Benezech, C., Nayar, S., Finney, B. A., Withers, D. R., Lowe, K., Desanti, G. E., Marriott, C. L. et al., CLEC-2 is required for development and maintenance of lymph nodes. Blood 2014. 123: 3200-3207.
13. Herzog, B. H., Fu, J., Wilson, S. J., Hess, P. R., Sen, A., McDaniel, J. M., Pan, Y. et al., Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature 2013. 502: 105-109.
14. Acton, S. E., Farrugia, A. J., Astarita, J. L., Mourao-Sa, D., Jenkins, R. P., Nye, E., Hooper, S. et al., Dendritic cells control fibroblastic reticular network tension and lymph node. Nature 2014. 514: 498-502.
15. Astarita, J. L., Cremasco, V., Fu, J., Darnell, M. C., Peck, J. R., Nieves-Bonilla, J. M., Song, K. et al., The CLEC-2-podoplanin axis controls the contractility of fibroblastic reticular cells and lymph node microarchitecture. Nat. Immunol. 2015. 16: 75-84.
16. Suzuki-Inoue, K., Fuller, G. L., Garcia, A., Eble, J. A., Pohlmann, S., Inoue, O., Gartner, T. K. et al., A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 2006. 107: 542-549.
17. Suzuki-Inoue, K., Kato, Y., Inoue, O., Kaneko, M. K., Mishima, K., Yatomi, Y., Yamazaki, Y. et al., Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J. Biol. Chem. 2007. 282: 25993-26001.
18. Neulen, M. L. and Gobel, T. W., Identification of a chicken CLEC-2 homologue, an activating C-type lectin expressed by thrombocytes. Immunogenetics 2012. 64: 389-397.
19. Kerrigan, A. M., Dennehy, K. M., Mourao-Sa, D., Faro-Trindade, I., Willment, J. A., Taylor, P. R., Eble, J. A. et al., CLEC-2 is a phagocytic activation receptor expressed on murine peripheral blood neutrophils. J. Immunol. 2009. 182: 4150-4157.
20. Tang, T., Li, L., Tang, J., Li, Y., Lin, W. Y., Martin, F., Grant, D. et al., A mouse knockout library for secreted and transmembrane proteins. Nat. Biotechnol. 2010. 28: 749-755.
21. Gitz, E., Pollitt, A. Y., Gitz-Francois, J. J., Alshehri, O., Mori, J., Montague, S., Nash, G. B. et al., CLEC-2 expression is maintained on activated platelets and on platelet microparticles. Blood 2014. 124: 2262-2270.
22. Del Rey, M. J., Fare, R., Izquierdo, E., Usategui, A., Rodriguez-Fernandez, J. L., Suarez-Fueyo, A., Canete, J. D. et al., Clinicopathological correlations of podoplanin (gp38) expression in rheumatoid synovium and its potential contribution to fibroblast platelet crosstalk. PLoS One 2014. 9: e99607.
23. Mourao-Sa, D., Robinson, M. J., Zelenay, S., Sancho, D., Chakravarty, P., Larsen, R., Plantinga, M. et al., CLEC-2 signaling via Syk in myeloid cells can regulate inflammatory responses. Eur. J. Immunol. 2011. 41: 3040-3053.
24. Acton, S. E., Astarita, J. L., Malhotra, D., Lukacs-Kornek, V., Franz, B., Hess, P. R., Jakus, Z. et al., Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2. Immunity 2012. 37: 276-289.
25. Hughes, C. E., Navarro-Nunez, L., Finney, B. A., Mourao-Sa, D., Pollitt, A. Y. and Watson, S. P., CLEC-2 is not required for platelet aggregation at arteriolar shear. J. Thromb. Haemost. 2010. 8: 2328-2332.
26. Cunningham, M. and Gilkeson, G., Estrogen receptors in immunity and autoimmunity. Clin. Rev. Allergy Immunol. 2011. 40: 66-73.
27. Kovats, S., Estrogen receptors regulate an inflammatory pathway of dendritic cell differentiation: mechanisms and implications for immunity. Horm. Behav. 2012. 62: 254-262.
28. Wu, W. M., Lin, B. F., Su, Y. C., Suen, J. L. and Chiang, B. L., Tamoxifen decreases renal inflammation and alleviates disease severity in autoimmune NZB/W F1 mice. Scand. J. Immunol. 2000. 52: 393-400.
29. Dayan, M., Zinger, H., Kalush, F., Mor, G., Amir-Zaltzman, Y., Kohen, F., Sthoeger, Z. et al., The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations. Immunology 1997. 90: 101-108.
30. Ostberg, J. R., Taylor, S. L., Baumann, H. and Repasky, E. A., Regulatory effects of fever-range whole-body hyperthermia on the LPS-induced acute inflammatory response. J. Leukoc. Biol. 2000. 68: 815-820.
31. May, F., Hagedorn, I., Pleines, I., Bender, M., Vogtle, T., Eble, J., Elvers, M. et al., CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis. Blood 2009. 114: 3464-3472.
32. Auffray, C., Fogg, D., Garfa, M., Elain, G., Join-Lambert, O., Kayal, S., Sarnacki, S. et al., Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007. 317: 666-670.
33. Sunderkotter, C., Nikolic, T., Dillon, M. J., Van Rooijen, N., Stehling, M., Drevets, D. A. and Leenen, P. J., Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 2004. 172: 4410-4417.
34. Peeva, E., Venkatesh, J. and Diamond, B., Tamoxifen blocks estrogen-induced B cell maturation but not survival. J. Immunol. 2005. 175: 1415-1423.
35. Nalbandian, G., Paharkova-Vatchkova, V., Mao, A., Nale, S. and Kovats, S., The selective estrogen receptor modulators, tamoxifen and raloxifene, impair dendritic cell differentiation and activation. J. Immunol. 2005. 175: 2666-2675.
36. Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J. et al., A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA 2004. 101: 6062-6067.
37. Mestas, J. and Hughes, C. C., Of mice and not men: differences between mouse and human immunology. J. Immunol. 2004. 172: 2731-2738.
38. Heng, T. S. and Painter, M. W., The immunological genome project: networks of gene expression in immune cells. Nat. Immunol. 2008. 9: 1091-1094.
39. Gottlieb, Y., Topaz, O., Cohen, L. A., Yakov, L. D., Haber, T., Morgenstern, A., Weiss, A. et al., Physiologically aged red blood cells undergo erythrophagocytosis in vivo but not in vitro. Haematologica 2012. 97: 994-1002.
40. Olsson, M., Bruhns, P., Frazier, W. A., Ravetch, J. V. and Oldenborg, P. A., Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia. Blood 2005. 105: 3577-3582.
41. Girard, J. P., Moussion, C. and Forster, R., HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat. Rev. Immunol. 2012. 12: 762-773.
42. Hwang, I. Y., Park, C., Harrison, K. and Kehrl, J. H., TLR4 signaling augments B lymphocyte migration and overcomes the restriction that limits access to germinal center dark zones. J. Exp. Med. 2009. 206: 2641-2657.
43. Hafezi-Moghadam, A. and Ley, K., Relevance of L-selectin shedding for leukocyte rolling in vivo. J. Exp. Med. 1999. 189: 939-948.
44. Strausbaugh, H. J., Green, P. G., Lo, E., Tangemann, K., Reichling, D. B., Rosen, S. D. and Levine, J. D., Painful stimulation suppresses joint inflammation by inducing shedding of L-selectin from neutrophils. Nat. Med. 1999. 5: 1057-1061.
45. Faveeuw, C., Preece, G. and Ager, A., Transendothelial migration of lymphocytes across high endothelial venules into lymph nodes is affected by metalloproteinases. Blood 2001. 98: 688-695.
46. Chen, J. R., Gu, B. J., Dao, L. P., Bradley, C. J., Mulligan, S. P. and Wiley, J. S., Transendothelial migration of lymphocytes in chronic lymphocytic leukaemia is impaired and involved down-regulation of both L-selectin and CD23. Br. J. Haematol. 1999. 105: 181-189.
47. Agenes, F., Rosado, M. M. and Freitas, A. A., Independent homeostatic regulation of B cell compartments. Eur. J. Immunol. 1997. 27: 1801-1807.
48. Flornes, L. M., Nylenna, O., Saether, P. C., Daws, M. R., Dissen, E. and Fossum, S., The complete inventory of receptors encoded by the rat natural killer cell gene complex. Immunogenetics 2010. 62: 521-530.
49. Ahmed, K. A. and Xiang, J., Mechanisms of cellular communication through intercellular protein transfer. J. Cell. Mol. Med. 2011. 15: 1458-1473.
50. Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J. et al., Restoration of p53 function leads to tumour regression in vivo. Nature 2007. 445: 661-665.
51. Zou, Y. R., Takeda, S. and Rajewsky, K., Gene targeting in the Ig kappa locus: efficient generation of lambda chain-expressing B cells, independent of gene rearrangements in Ig kappa. Embo. J. 1993. 12: 811-820.
52. Gu, H., Zou, Y. R. and Rajewsky, K., Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 1993. 73: 1155-1164.